5PLU-BUREAU Genevieve, LE Monique G, SITRUKWARE Regine, et al. Cyclical mastalgia and breast can- cer risk:results of a French cohort study[J]. Cancer epidemiology,2006,15(6):1229-1231.
6Oksa S, Luukkaala T, Maenpaa J. Toremifene for premenstrual mastalgia:a randomised,placebo-controlled crossover study[J]. BJOG,2006,113(6)713-718.
7Tonetti DA, O Regan R, Tanjore S, et al. Anti-estrogen stimulate human endometrial cancer growth:laboratory and clinical consideration[J]. J Steroid Biochem Mol Biol, 1998,65:181-189.
8Shaaban MM, Alagatnan IT, Scanlon FF, et al. Treatment of fibrocystic mastopathy by, sn antiestrogen,tamoxifen Int [J]. Gyaccol Obstet,1980,18(5)348-352.
9O.Dudnichenko, et al. Toremifen in treatment of precancerous breast diseases [J]. European Journal Of Cancer Supplements,2005,3(2): 110.
10Erkkola R, Mattila L, Powles T, et al. Bone mineral density and lipid changes during 5 years of follow-up in a study of prevention of breast cancer with toremifene in healthy, high-risk pre- and post-menopausal women [J]. Breast Cancer Res Treat. 2005 Oct;93(3):277-87.
7Hamed H,Kotheri A,Beechey-Newman N,et al.Toremifene,a new agent for t reatment of mastalgia:an open study[J].Int J Fertil Womens Med,2004,49(6):278-280.
10Oksa S,Luukkaala T,M(a)enp(aa) J. Toremifene for premenstrual mastalgia:a randomised,placebo-controlled crossover study[J].British Journal of Obstetrics and Gynaecology,2006,(06):713-718.
